An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection.

Natalia BlancoBetsy FoxmanAnurag N MalaniMin ZhangSeth WalkAlexander H RickardMarisa C Eisenberg

Published in: PloS one (2017)

Current CDI vancomycin regimen for treating recurrent cases should be studied further to better balance associated risks and benefits.

Keyphrases